Research Project
Edel O'Hagan
Current Appointments
Postdoctoral Research FellowEdel O’Hagan is an early career researcher at Westmead Applied Research Centre and a registered Physiotherapist. She also holds an honorary Research Fellow position at Neuroscience Research Australia in the Centre for Pain IMPACT. She completed her PhD at NeuRA, UNSW, which focused on understanding patient information from the perspective of consumers to facilitate patient-centred care.
Edel's postdoctoral research focuses on enhancing care for people with chronic conditions using digital technologies.
Publications
2024 Feb
Using hypnosis in clinical practice for the management of chronic pain: A qualitative study
View full journal-article on http://dx.doi.org/10.1016/j.pec.2023.108097
2024 Jan
Smartphone Applications to Prevent Type 2 Diabetes: A Systematic Review and Meta-Analysis
View full journal-article on http://dx.doi.org/10.1016/j.amepre.2024.01.008
2023 Dec
Lifestyle changes and quality of life a year after attending Rapid Access Cardiology Clinics: an observational study
View full journal-article on http://dx.doi.org/10.1111/imj.16289
2023 Dec
Mechanisms of education and graded sensorimotor retraining in people with chronic low back pain: a mediation analysis
View full journal-article on http://dx.doi.org/10.1097/j.pain.0000000000002978
2023, 07 Sep
Who are community self-check blood pressure kiosks serving?
2023 Jul
Online information on chronic pain in 3 countries: an assessment of readability, credibility, and accuracy
View full journal-article on http://dx.doi.org/10.1097/pr9.0000000000001078
2023, 16 Jun
Potential for a Chat-Based Artificial Intelligence Model to Facilitate Educational Messaging on Hypertension
View full journal-article on http://dx.doi.org/10.1161/hypertensionaha.123.21395
2023, 03 Apr
Pain in the media
View full lecture-speech on https://www.dcconferences.com.au/aps2023/Pain_in_the_Media
2023, 06 Mar
Optimising education interventions to support self-management of low back pain
2023, 21 Feb
Hypertension therapy using fixed-dose polypills that contain at least three medications
View full journal-article on http://dx.doi.org/10.1136/heartjnl-2022-321496